A study showed that FIX are barely activated in hemophilia B patients with p.Gly94Arg and p.Gly94Val mutations that disrupt the interaction of FIX with TF/FVIIa complex [85], indicating that the EGF1 domain is essential for this interaction. The gene discussed is F9; the disease is hemophilia B.